Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04887285
Other study ID # IRB00255275
Secondary ID HU00011920011
Status Completed
Phase N/A
First received
Last updated
Start date March 28, 2022
Est. completion date August 15, 2023

Study information

Verified date October 2023
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study examines the impact of virtual reality compared to sedation (midazolam and/or fentanyl) and no intervention on pain experienced from an epidural steroid injection (ESI). The intervention group (who receive virtual reality as a distraction modality) is compared to a sedation group and a control group.


Description:

All patients enrolled in the study will already be undergoing lumbar epidural steroid injections for lumbar radicular pain as part of their clinical care. The epidural approach will either be transforaminal or interlaminar depending on clinical judgment (i.e. transforaminal ESI for unilateral pain, interlaminar ESI for bilateral pain). The study will consist of 3 groups: virtual reality, sedation, and a control group which receives no intervention (i.e. standard of care). The virtual reality group will receive virtual reality via a headset containing a menu of 6 programs that the subject can choose; the sedation group will receive from 1-5 mg of midazolam and up to 150 mcg of fentanyl as clinically indicated, and the control group will not receive an intervention (standard of care). All subjects will also receive 1% lidocaine local anesthetic through a 25-gauge needle for superficial anesthesia, which is standard of care. Subjects will be randomized to each of these groups, with sub-allocation being done stratified by the type of ESI (transforaminal vs. interlaminar). A secondary pilot study will evaluate whether a processed electroencephalogram (pEEG) and continuous colored density spectral array monitored via a four-channel Masimo SEDLine frontal EEG sensor can serve as a biomarker for painful stimulation and the effectiveness of distraction and sedation to reduce acute pain.


Recruitment information / eligibility

Status Completed
Enrollment 146
Est. completion date August 15, 2023
Est. primary completion date August 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Males and females; ages 18-90 years - Lumbosacral radicular pain with a baseline average of leg pain score of > 4/10, MRI findings (if available) consistent with symptoms, duration of pain > 6 weeks, and no previous lumbar spine surgery. - Documented diagnosis of radicular pain caused by herniated disc, central stenosis, foraminal stenosis, degenerative disk disease - Willingness to adhere to undergo ESI with either sedation (midazolam and or fentanyl) or with virtual reality - Able to appear for a follow up visit between 24-40 days following the intervention Exclusion Criteria: - MRI findings discordant with symptoms (absence of herniated disc, spinal stenosis or severe disc degeneration without nerve root impingement (e.g. annular tears) that could explain symptoms) - Previous lumbosacral spine surgery at the area affected - Prior ESI within the past 6 months - Allergy to contrast dye - Poorly controlled psychiatric conditions that could affect outcomes (e.g. active substance abuse) or impose a barrier to participation (e.g. anxiety disorder requiring procedural sedation) - Morbid obesity (BMI >40)

Study Design


Intervention

Device:
Virtual reality
Subjects in the virtual reality group will be offered a variety of immersive environments to choose from (mountains, beach, rainforest and temperate forest) in addition to local anesthetic.
Drug:
Intravenous sedation
Sedation will be administered using low-dose midazolam and/ or fentanyl. We will use a wide range of dosing (1-5 mg for midazolam, up to 150 mcg for fentanyl) to maximize generalizability and account for widespread variability in clinical circumstances, medical practice and patient response (personalized medicine). Sedation will be titrated to effect by a board-certified or eligible anesthesiologist so that patients remain responsive to verbal stimuli.
Other:
Standard care
Patients will receive superficial local anesthetic with 1% lidocaine. Local anesthetic will be administered by the physician performing the procedure titrated to patient comfort.

Locations

Country Name City State
United States Johns Hopkins Medical Institutions Baltimore Maryland

Sponsors (6)

Lead Sponsor Collaborator
Johns Hopkins University Brigham and Women's Hospital, The Geneva Foundation, United States Department of Defense, United States Naval Medical Center, San Diego, Walter Reed National Military Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (2)

Indovina P, Barone D, Gallo L, Chirico A, De Pietro G, Giordano A. Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures: A Comprehensive Literature Review. Clin J Pain. 2018 Sep;34(9):858-877. doi: 10.1097/A — View Citation

Mallari B, Spaeth EK, Goh H, Boyd BS. Virtual reality as an analgesic for acute and chronic pain in adults: a systematic review and meta-analysis. J Pain Res. 2019 Jul 3;12:2053-2085. doi: 10.2147/JPR.S200498. eCollection 2019. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain score during procedure 0-10 verbal rating scale (higher scores indicate greater pain) Immediately after procedure
Secondary Amount of local anesthetic required Volume of 1% lidocaine used to complete procedure Immediately after procedure
Secondary Subcutaneous skin wheal pain score 0-10 verbal rating scale (higher scores indicate greater pain) Immediately after skin wheal
Secondary Procedure satisfaction 1-5 Likert scale (1= very unsatisfied, 3= neither satisfied nor dissatisfied, 5= very satisfied) In postanesthetic care unit (within 1 hour)
Secondary Ability to communicate 1-5 Likert scale (1= complete inability to communicate with physician, 2= markedly decreased ability to communicate, 3= slightly decreased ability to communicate, 4= no change in ability to communicate, 5= improved ability to communicate) In postanesthetic care unit (within 1 hour)
Secondary Procedure-related anxiety 1-5 Likert scale (1=extreme anxiety, 2=high anxiety, 3=average or expected anxiety, 2=minimal or mild anxiety, 5=no anxiety In postanesthetic care unit (within 1 hour)
Secondary Time to discharge from postanesthetic care unit Time to discharge from postanesthetic care unit, in minutes At discharge from postanesthetic care unit assessed up to 6 hours
Secondary Categorical outcome Positive (2-point or greater reduction in average leg pain score coupled with score of 5 or greater on PGIC) or negative 1-month
Secondary Average leg pain score Average leg pain score on 0-10 numerical rating scale over the last week (higher pain scores indicate greater pain) 1-month
Secondary Worst leg pain score Worst leg pain score on 0-10 numerical rating scale over the last week (higher pain scores indicate greater pain) 1-month
Secondary Average back pain score Average back pain score on 0-10 numerical rating scale over the last week (higher pain scores indicate greater pain) 1-month
Secondary Worst back pain score Worst back pain score on 0-10 numerical rating scale over the last week (higher pain scores indicate greater pain) 1-month
Secondary Patient global impression of change (PGIC) Patient global impression of change on 7-point Likert scale (from 1= no change, 3= a little better 5= moderately better, a slight but noticeable change, to 7=a great deal better, a considerable improvement that has made all the difference) 1-month
Secondary Analgesic reduction Categorical reduction in analgesic usage (cessation of non-opioid analgesic and/ or > 20% reduction in opioid use) 1-month
Secondary Oswestry disability index (ODI) score Functional measurement of back and leg pain disability on 0-100% scale (higher levels indicate greater disability) 1-month
Secondary Hospital anxiety and depression scale (HADS) scores Instrument to measure depression and anxiety, each on 21-point scale (higher levels indicate greater anxiety and depression) 1-month
Secondary Complications Complications related to the procedure, sedation or use of virtual reality 1-month
Secondary Processed electroencephalogram (pEEG) and continuous colored density spectral array Frontal EEG sensor will be placed with electrode positions corresponding to Fp1, Fp2, F7, and F8 in the international 10-20 system. The median power across channels is computed across different wave forms (delta through beta). Power spectral analysis and spectral edge frequency calculations will be performed. During the procedure for up to 20 minutes
See also
  Status Clinical Trial Phase
Terminated NCT05047679 - The Effectiveness of Pain Neuroscience Education in At-risk Patients Following Surgery for Lumbar Radiculopathy N/A
Withdrawn NCT03543033 - Preoperative Corticosteroid Epidural Injection and Lumbar Decompression Surgery Outcomes N/A
Recruiting NCT06076408 - Effects of SNAGS With and Without Pilates in Lumbar Disc Bulge Patients N/A
Completed NCT03133845 - Shaping Anesthetic Techniques to Reduce Post-operative Delirium N/A
Completed NCT06087107 - Comparative Effects Of High Intensity Spinal Decompression Exercises And Eldoa In Patients Of Lumbar Radiculopathy N/A
Completed NCT04852900 - Different Dosage of Decompression Therapy on Symptoms of Lumbar Radiculopathy N/A
Terminated NCT05022251 - Identifying Pain Generators and Potentiators of Residual Complaints Following Lumbar Discectomy
Recruiting NCT04212949 - The Effect of Transcranial Magnetic Stimulation Therapy in Patients With Lumbar Radiculopathy N/A
Terminated NCT03952377 - Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain Phase 1/Phase 2
Recruiting NCT06339931 - Lumber Spine Mobilization and Spinal Traction on Lumber Radiculopathy. N/A
Recruiting NCT04540068 - Prediction of TEI Success in Sciatica
Recruiting NCT05922228 - Effects of Neural Flossing and PNF on Lumbar Radiculopathy N/A
Recruiting NCT05953727 - Low Level LASER Therapy With and Without Proprioceptive Stimulation Among Discogenic Lumbar Radiculopathy Patients N/A
Completed NCT05449288 - Urdu Version Of Modified Oswestry Low Back Pain Scale; A Reliability And Validity Study
Completed NCT05874427 - Comparison Between the Imaging Consent Form and the Existing Narrative Consent Form N/A
Terminated NCT01443819 - Lumbar Transforaminal Epidural Corticosteroid Injection(s) Versus Defined Physical Therapy Phase 3
Recruiting NCT05535010 - The Effect of the Presence of Active Trigger Points in the Muscles Innervated by the Affected Nerve Roots on the Treatment Results of Transforaminal Epidural Steroid Injection in Patients With Lumbar Radiculopathy. N/A
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Completed NCT04674917 - Effects of Decompression in Patient With Acute vs Chronic Lumbar Radiculopathy N/A
Not yet recruiting NCT06296303 - Effect of Pulsed Magnetic Therapy Versus Phonophoresis in Discogenic Lumbar Radiculopathy Patients N/A